1 Patent
- US118195142023Use of Oligosaccharide Riclinoctaose in Preparation of Drug for Treating And/or Preventing Ischemia-reperfusion Injury (IRI)
Nanjing Southern Element Biotechnology Co., Ltd.
0 cites
Nanjing Southern Element Biotechnology Co., Ltd.